Scheme 1.
Schematic illustration of the molecular tuning of IR-786 for enhanced photothermal cancer therapy. The integration of a chloro-cyclohexene ring and side carboxyl groups on the heptamethine skeleton is the key to improving tumor targetability based on a structure-inherent targeting strategy.